Unwholesome heart (Hypercholesterolemia) and naturally available drugs: A comprehensive review

Abstract

Hypercholesterolemia is a common disorder in developed countries. It refers to abnormalities in lipid metabolism, plasma lipid transport, or a disorder in the synthesis and degradation of plasma lipoproteins which leads to a high level of fat in the blood. The utilization of natural medicines for the treatment of several diseases and disorders dates back to ancient times. A lot of herbal medicines have got their place on the world market as options to the prescribed drugs to manage and treat various ailments. Hypercholesterolemia contributes a lot to the manifestation and development of atherosclerosis and coronary heart disease (CHD). Hypercholesterolemia prevalence continued to increase annually, requiring the development of drugs capable of lowering blood lipids to check death rate and morbidity due to cardiovascular complications. The current review is designed to gather knowledge about the Management and treatment of hypercholesterolemia, using drugs from Natural sources as the cornerstone instrument. Although synthetic lipid-lowering drugs are useful in treating Hypercholesterolemia, there are several adverse effects. So the use of herbal drugs is eminent as the cornerstone tool, for mitigation, prevention, and treatment of Hypercholesterolemia to address the said ailment. This review aims to provide benefits from numerous lipid-lowering agents with minimal or no side effects from natural sources, where the naturally available drugs can be taken as a means of the normal routine diet without any specific care.

References

1. F. Sanchis-Gomar, C. Perez-Quilts, R. Leischik, and A. Lucia, "Epidemiology of coronary heart disease and acute coronary syndrome," (in eng), Ann Transl Med, vol. 4, no. 13, pp. 256-256, 2016, doi: 10.21037/atm.2016.06.33.
2. Shabana, S. U. Shahid, and S. Sarwar, "The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects," (in eng), Lipids Health Dis, vol. 19, no. 1, pp. 73-73, 2020, doi: 10.1186/s12944-020-01248-0.
3. "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report," (in eng), Circulation, vol. 106, no. 25, pp. 3143-421, Dec 17 2002.
4. M. J. Stampfer, F. B. Hu, J. E. Manson, E. B. Rimm, and W. C. Willett, "Primary prevention of coronary heart disease in women through diet and lifestyle," (in eng), N Engl J Med, vol. 343, no. 1, pp. 16-22, Jul 6 2000, doi: 10.1056/nejm200007063430103.
5. P. Hu et al., "Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis," (in eng), Circulation, vol. 141, no. 22, pp. 1742-1759, Jun 2 2020, doi: 10.1161/circulationaha.119.044795.
6. J. A. Halverson, E. Barnett, and M. Casper, "Geographic disparities in heart disease and stroke mortality among black and white populations in the Appalachian region," Ethnicity and Disease, vol. 12, no. 4, pp. S3-82, 2002.
7. D. Mozaffarian et al., "Heart disease and stroke statistics—2016 update: a report from the American Heart Association," circulation, vol. 133, no. 4, pp. e38-e360, 2016.
8. S. Pal. Hypercholesterolemia Trends. US Pharmacist.
9. S. Karr, "Epidemiology and management of hyperlipidemia," (in eng), Am J Manag Care, vol. 23, no. 9 Suppl, pp. S139-s148, Jun 2017.
10. R. Gupta, R. S. Rao, A. Misra, and S. K. Sharma, "Recent trends in epidemiology of dyslipidemias in India," Indian Heart Journal, vol. 69, no. 3, pp. 382-392, 2017/05/01/ 2017, doi: https://doi.org/10.1016/j.ihj.2017.02.020.
11. S. Yusuf et al., "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study," (in eng), Lancet, vol. 364, no. 9438, pp. 937-52, Sep 11-17 2004, doi: 10.1016/s0140-6736(04)17018-9.
12. A. Keys, J. T. Anderson, and F. Grande, "Prediction of serum-cholesterol responses of man to changes in fats in the diet," (in eng), Lancet, vol. 273, no. 7003, pp. 959-66, Nov 16 1957, doi: 10.1016/s0140-6736(57)91998-0.
13. A. K. Malakar, D. Choudhury, B. Halder, P. Paul, A. Uddin, and S. Chakraborty, "A review on coronary artery disease, its risk factors, and therapeutics," (in eng), Journal of cellular physiology, vol. 234, no. 10, pp. 16812-16823, Aug 2019, doi: 10.1002/jcp.28350.
14. A. H. Lichtenstein, "Thematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns," (in eng), J Lipid Res, vol. 47, no. 8, pp. 1661-7, Aug 2006, doi: 10.1194/jlr.R600019-JLR200.
15. A. Mente, L. de Koning, H. S. Shannon, and S. S. Anand, "A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease," (in eng), Arch Intern Med, vol. 169, no. 7, pp. 659-69, Apr 13 2009, doi: 10.1001/archinternmed.2009.38.
16. E. Ros, L. C. Tapsell, and J. Sabaté, "Nuts and berries for heart health," (in eng), Curr Atheroscler Rep, vol. 12, no. 6, pp. 397-406, Nov 2010, doi: 10.1007/s11883-010-0132-5.
17. L. A. Bazzano, A. M. Thompson, M. T. Tees, C. H. Nguyen, and D. M. Winham, "Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials," (in eng), Nutr Metab Cardiovasc Dis, vol. 21, no. 2, pp. 94-103, Feb 2011, doi: 10.1016/j.numecd.2009.08.012.
18. A. E. Ibrahim MA, Jialal I, Hypercholesterolemia. StatPearls Publishing, 2022.
19. P. S. Nijjar, F. M. Burke, A. Bloesch, and D. J. Rader, "Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review," (in eng), J Clin Lipidol, vol. 4, no. 4, pp. 248-58, Jul-Aug 2010, doi: 10.1016/j.jacl.2010.07.001.
20. D. Hammersley and M. Signy, "Ezetimibe: an update on its clinical usefulness in specific patient groups," (in eng), Ther Adv Chronic Dis, vol. 8, no. 1, pp. 4-11, Jan 2017, doi: 10.1177/2040622316672544.
21. D. J. Rader and J. J. Kastelein, "Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia," Circulation, vol. 129, no. 9, pp. 1022-1032, 2014.
22. E. Ajufo and D. J. Rader, "Recent advances in the pharmacological management of hypercholesterolaemia," (in eng), Lancet Diabetes Endocrinol, vol. 4, no. 5, pp. 436-46, May 2016, doi: 10.1016/s2213-8587(16)00074-7.
23. V. Vadivel, C. N. Kunyanga, and H. K. Biesalski, "Health benefits of nut consumption with special reference to body weight control," (in eng), Nutrition, vol. 28, no. 11-12, pp. 1089-97, Nov-Dec 2012, doi: 10.1016/j.nut.2012.01.004.
24. S. Natoli and P. McCoy, "A review of the evidence: nuts and body weight," (in eng), Asia Pac J Clin Nutr, vol. 16, no. 4, pp. 588-97, 2007.
25. M. Semalty, A. Semalty, A. Badola, G. P. Joshi, and M. S. Rawat, "Semecarpus anacardium Linn.: A review," (in eng), Pharmacogn Rev, vol. 4, no. 7, pp. 88-94, Jan 2010, doi: 10.4103/0973-7847.65328.
26. A. Sharma, R. Mathur, and V. P. Dixit, "Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits," (in eng), Indian J Exp Biol, vol. 33, no. 6, pp. 444-8, Jun 1995.
27. N. K. Mary, B. H. Babu, and J. Padikkala, "Antiatherogenic effect of Caps HT2, a herbal Ayurvedic medicine formulation," Phytomedicine, vol. 10, no. 6, pp. 474-482, 2003/01/01/ 2003, doi: https://doi.org/10.1078/094471103322331412.
28. P. O. Szapary et al., "Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial," (in eng), Jama, vol. 290, no. 6, pp. 765-72, Aug 13 2003, doi: 10.1001/jama.290.6.765.
29. L. A. Nohr, L. B. Rasmussen, and J. Straand, "Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study," (in eng), Complement Ther Med, vol. 17, no. 1, pp. 16-22, Jan 2009, doi: 10.1016/j.ctim.2008.07.001.
30. S. Dev, "Ancient-modern concordance in Ayurvedic plants: some examples," (in eng), Environ Health Perspect, vol. 107, no. 10, pp. 783-789, 1999, doi: 10.1289/ehp.99107783.
31. C. Ulbricht et al., "Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration," (in eng), Complement Ther Med, vol. 13, no. 4, pp. 279-90, Dec 2005, doi: 10.1016/j.ctim.2005.08.003.
32. S. Shishodia, K. B. Harikumar, S. Dass, K. G. Ramawat, and B. B. Aggarwal, "The guggul for chronic diseases: ancient medicine, modern targets," (in eng), Anticancer research, vol. 28, no. 6a, pp. 3647-64, Nov-Dec 2008.
33. J. López-Miranda et al., "Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008," Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 4, pp. 284-294, 2010/05/01/ 2010, doi: https://doi.org/10.1016/j.numecd.2009.12.007.
34. A. Jiménez-Sánchez, A. J. Martínez-Ortega, P. J. Remón-Ruiz, A. Piñar-Gutiérrez, J. L. Pereira-Cunill, and P. P. García-Luna, "Therapeutic Properties and Use of Extra Virgin Olive Oil in Clinical Nutrition: A Narrative Review and Literature Update," Nutrients, vol. 14, no. 7, 2022, doi: 10.3390/nu14071440.
35. K. Cullinen, "Olive oil in the treatment of hypercholesterolemia," Medicine and health, Rhode Island, vol. 89, p. 113, 04/01 2006.
36. D. J. Jenkins et al., "Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia," (in eng), Cmaj, vol. 182, no. 18, pp. 1961-7, Dec 14 2010, doi: 10.1503/cmaj.092128.
37. A. Wiegman et al., "Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment," (in eng), Eur Heart J, vol. 36, no. 36, pp. 2425-2437, 2015, doi: 10.1093/eurheartj/ehv157.
38. T. G. Albuquerque, M. A. Nunes, S. M. F. Bessada, H. S. Costa, and M. B. P. P. Oliveira, "14 - Biologically active and health promoting food components of nuts, oilseeds, fruits, vegetables, cereals, and legumes," in Chemical Analysis of Food (Second Edition), Y. Pico Ed.: Academic Press, 2020, pp. 609-656.
39. L. A. Bazzano et al., "Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study," (in eng), Arch Intern Med, vol. 161, no. 21, pp. 2573-8, Nov 26 2001, doi: 10.1001/archinte.161.21.2573.
40. B. Olmedilla-Alonso, A. M. Benítez-González, R. Estévez-Santiago, P. Mapelli-Brahm, C. M. Stinco, and A. J. Meléndez-Martínez, "Assessment of Food Sources and the Intake of the Colourless Carotenoids Phytoene and Phytofluene in Spain," Nutrients, vol. 13, no. 12, 2021, doi: 10.3390/nu13124436.
41. B. Fuhrman, A. Elis, and M. Aviram, "Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages," (in eng), Biochemical and biophysical research communications, vol. 233, no. 3, pp. 658-62, Apr 28 1997, doi: 10.1006/bbrc.1997.6520.
42. S. U. Islam, M. B. Ahmed, H. Ahsan, and Y.-S. Lee, "Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease," (in eng), Antioxidants (Basel), vol. 10, no. 5, p. 784, 2021, doi: 10.3390/antiox10050784.
43. R. Corti, A. Flammer, N. Hollenberg, and T. Lüscher, "Cocoa and Cardiovascular Health," Circulation, vol. 119, pp. 1433-41, 04/01 2009, doi: 10.1161/CIRCULATIONAHA.108.827022.
44. O. A. Tokede, J. M. Gaziano, and L. Djoussé, "Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis," (in eng), Eur J Clin Nutr, vol. 65, no. 8, pp. 879-86, Aug 2011, doi: 10.1038/ejcn.2011.64.
45. A. Ruzaidi, I. Amin, A. G. Nawalyah, M. Hamid, and H. A. Faizul, "The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats," (in eng), J Ethnopharmacol, vol. 98, no. 1-2, pp. 55-60, Apr 8 2005, doi: 10.1016/j.jep.2004.12.018.
46. E. Lecumberri et al., "A diet rich in dietary fiber from cocoa improves lipid profile and reduces malondialdehyde in hypercholesterolemic rats," (in eng), Nutrition, vol. 23, no. 4, pp. 332-41, Apr 2007, doi: 10.1016/j.nut.2007.01.013.
47. J. A. Polagruto, J. F. Wang-Polagruto, M. M. Braun, L. Lee, C. Kwik-Uribe, and C. L. Keen, "Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels," (in eng), J Am Diet Assoc, vol. 106, no. 11, pp. 1804-13, Nov 2006, doi: 10.1016/j.jada.2006.08.012.
48. J. A. Story et al., "Interactions of alfalfa plant and sprout saponins with cholesterol in vitro and in cholesterol-fed rats," (in eng), Am J Clin Nutr, vol. 39, no. 6, pp. 917-29, Jun 1984, doi: 10.1093/ajcn/39.6.917.
49. Y. Shi et al., "The regulation of alfalfa saponin extract on key genes involved in hepatic cholesterol metabolism in hyperlipidemic rats," (in eng), PloS one, vol. 9, no. 2, pp. e88282-e88282, 2014, doi: 10.1371/journal.pone.0088282.
50. T. Kiho, A. Yamane, J. Hui, S. Usui, and S. Ukai, "Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver," (in eng), Biol Pharm Bull, vol. 19, no. 2, pp. 294-6, Feb 1996, doi: 10.1248/bpb.19.294.
51. T.-H. Hsu, C.-H. Lee, F.-Y. Lin, S. P. Wasser, and H.-C. Lo, "The Fruiting Bodies, Submerged Culture Biomass, and Acidic Polysaccharide Glucuronoxylomannan of Yellow Brain Mushroom Tremella mesenterica Modulate the Immunity of Peripheral Blood Leukocytes and Splenocytes in Rats with Impaired Glucose Tolerance," (in eng), J Tradit Complement Med, vol. 4, no. 1, pp. 56-63, 2014, doi: 10.4103/2225-4110.124347.
52. C. Murphy, E. Deplazes, C. G. Cranfield, and A. Garcia, "The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins," (in eng), Int J Mol Sci, vol. 21, no. 22, Nov 19 2020, doi: 10.3390/ijms21228745.
53. W. Forsythe, E. Miller, G. Hill, D. Romsos, and R. Simpson, "Effects of Dietary Protein and Fat Sources on Plasma Cholesterol Parameters, LCAT Activity and Amino Acid Levels and on Tissue Lipid Content of Growing Pigs2," The Journal of nutrition, vol. 110, pp. 2467-79, 01/01 1981, doi: 10.1093/jn/110.12.2467.
54. D. J. Jenkins et al., "The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia," (in eng), Metabolism, vol. 52, no. 11, pp. 1478-83, Nov 2003, doi: 10.1016/s0026-0495(03)00260-9.
55. S. H. Chu and D. M. Hegsted, "Adaptive response of lysine and threonine degrading enzymes in adult rats," (in eng), J Nutr, vol. 106, no. 8, pp. 1089-96, Aug 1976, doi: 10.1093/jn/106.8.1089.
56. M. Salazar, E. Martínez, E. Madrigal, L. E. Ruiz, and G. A. Chamorro, "Subchronic toxicity study in mice fed Spirulina maxima," (in eng), J Ethnopharmacol, vol. 62, no. 3, pp. 235-41, Oct 1998, doi: 10.1016/s0378-8741(98)00080-4.
57. S. Mokady and I. E. Liener, "Effect of Plant Proteins on Cholesterol Metabolism in Growing Rats Fed Atherogenic Diets," Annals of Nutrition and Metabolism, vol. 26, no. 2, pp. 138-144, 1982, doi: 10.1159/000176556.
58. I. Gusti Ayu Nyoman Danuyanti and Z. S. Ahmad Fahrurrozi, "Dietary Fiber and Dyslipidemia," in Dietary Fibers, ed: IntechOpen, 2022.
59. N. P. V. P and I. J. Joye, "Dietary Fibre from Whole Grains and Their Benefits on Metabolic Health," (in eng), Nutrients, vol. 12, no. 10, p. 3045, 2020, doi: 10.3390/nu12103045.
60. J. W. Anderson et al., "Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials," (in eng), Am J Clin Nutr, vol. 71, no. 2, pp. 472-9, Feb 2000, doi: 10.1093/ajcn/71.2.472.
61. L. Brown, B. Rosner, W. W. Willett, and F. M. Sacks, "Cholesterol-lowering effects of dietary fiber: a meta-analysis," (in eng), Am J Clin Nutr, vol. 69, no. 1, pp. 30-42, Jan 1999, doi: 10.1093/ajcn/69.1.30.
62. W. J. Chen, J. W. Anderson, and D. Jennings, "Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats," (in eng), Proc Soc Exp Biol Med, vol. 175, no. 2, pp. 215-8, Feb 1984, doi: 10.3181/00379727-175-41791.
63. K. A. Harris and P. M. Kris-Etherton, "Effects of whole grains on coronary heart disease risk," (in eng), Curr Atheroscler Rep, vol. 12, no. 6, pp. 368-76, Nov 2010, doi: 10.1007/s11883-010-0136-1.
64. M. Govindappa, "A Review on Role of Plant(s) Extracts and its Phytochemicals for the Management of Diabetes," Journal of diabetes & metabolism, vol. 6, pp. 1-38, 2015.
65. D. J. Jenkins et al., "A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia," (in eng), Metabolism, vol. 51, no. 12, pp. 1596-604, Dec 2002, doi: 10.1053/meta.2002.35578.
66. D. J. Jenkins et al., "Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants," (in eng), Am J Clin Nutr, vol. 81, no. 2, pp. 380-7, Feb 2005, doi: 10.1093/ajcn.81.2.380.
67. R. Gebhardt and H. Beck, "Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures," (in eng), Lipids, vol. 31, no. 12, pp. 1269-76, Dec 1996, doi: 10.1007/bf02587912.
68. S. Warshafsky, R. S. Kamer, and S. L. Sivak, "Effect of garlic on total serum cholesterol. A meta-analysis," (in eng), Ann Intern Med, vol. 119, no. 7 Pt 1, pp. 599-605, Oct 1 1993, doi: 10.7326/0003-4819-119-7_part_1-199310010-00009.
69. Y. Y. Yeh and L. Liu, "Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies," (in eng), J Nutr, vol. 131, no. 3s, pp. 989s-93s, Mar 2001, doi: 10.1093/jn/131.3.989S.
70. M. S. Chi, E. T. Koh, and T. J. Stewart, "Effects of Garlic on Lipid Metabolism in Rats Fed Cholesterol or Lard," The Journal of Nutrition, vol. 112, no. 2, pp. 241-248, 1982, doi: 10.1093/jn/112.2.241.
71. D. Heber, I. Yip, J. M. Ashley, D. A. Elashoff, R. M. Elashoff, and V. L. W. Go, "Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement," The American Journal of Clinical Nutrition, vol. 69, no. 2, pp. 231-236, 1999, doi: 10.1093/ajcn/69.2.231.
72. C. Li, Y. Zhu, Y. Wang, J.-S. Zhu, J. Chang, and D. Kritchevsky, "Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res," Nutrition research, vol. 18, pp. 71-81, 01/01 1998, doi: 10.1016/S0271-5317(97)00201-7.
73. V. Verhoeven, M. Lopez Hartmann, R. Remmen, J. Wens, S. Apers, and P. Van Royen, "Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial," (in eng), BMC Complement Altern Med, vol. 13, p. 178, Jul 18 2013, doi: 10.1186/1472-6882-13-178.
74. W. Wei, C. Li, Y. Wang, H. Su, J. Zhu, and D. Kritchevsky, "Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits," (in eng), J Nutr Biochem, vol. 14, no. 6, pp. 314-8, Jun 2003, doi: 10.1016/s0955-2863(03)00051-2.
75. M. P. Bogsrud et al., "HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study," (in eng), Scand Cardiovasc J, vol. 44, no. 4, pp. 197-200, Aug 2010, doi: 10.3109/14017431003624123.
76. W. H. Chang and J. F. Liu, "Effects of kiwifruit consumption on serum lipid profiles and antioxidative status in hyperlipidemic subjects," (in eng), Int J Food Sci Nutr, vol. 60, no. 8, pp. 709-16, Dec 2009, doi: 10.3109/09637480802063517.
77. I. Zanotti et al., "Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism," (in eng), Food Funct, vol. 6, no. 1, pp. 13-31, Jan 2015, doi: 10.1039/c4fo00670d.
78. K. Tebib, L. Bitri, P. Besançon, and J.-M. Rouanet, "Polymeric grape seed tannins prevent plasma cholesterol changes in high-cholesterol-fed rats," Food Chemistry, vol. 49, no. 4, pp. 403-406, 1994/01/01/ 1994, doi: https://doi.org/10.1016/0308-8146(94)90012-4.
79. N. Yousofvand, "Effects of Hydroalcoholic Extract of Dill (Anethum graveolens) on the serum levels of blood lipids (cholesterol, Triglycerides, LDL and HDL) in male NMRI mice," 05/01 2015.
80. D. Miura, Y. Miura, and K. Yagasaki, "Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats," Life sciences, vol. 73, pp. 1393-400, 09/01 2003, doi: 10.1016/S0024-3205(03)00469-7.
81. M. Emadi, H. Kermanshahi, and E. Maroufyan, "Effect of Varying Levels of Turmeric Rhizome Powder on Some Blood Parameters of Broiler Chickens Fed Corn-Soybean Meal Based Diets," International Journal of Poultry Science, vol. 6, 05/01 2007, doi: 10.3923/ijps.2007.345.348.
82. I. Budiman, R. Tjokropranoto, W. Widowati, N. Fauziah, and P. P. Erawijantari, "Potency of turmeric (Curcuma longa L.) extract and curcumin as anti-obesity by inhibiting the cholesterol and triglycerides synthesis in HepG2 cells," Int. J. Res. Med. Sci, vol. 3, no. 5, pp. 1165-1171, 2015.
83. A. J. Akinyemi, G. Oboh, A. O. Ademiluyi, A. A. Boligon, and M. L. Athayde, "Effect of Two Ginger Varieties on Arginase Activity in Hypercholesterolemic Rats," (in eng), J Acupunct Meridian Stud, vol. 9, no. 2, pp. 80-7, Apr 2016, doi: 10.1016/j.jams.2015.03.003.
84. R. A. Anderson et al., "Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose," (in eng), J Tradit Complement Med, vol. 6, no. 4, pp. 332-336, Oct 2016, doi: 10.1016/j.jtcme.2015.03.005.
85. S. Rahman, H. Begum, Z. Rahman, F. Ara, M. J. Iqbal, and A. K. M. Yousuf, "Effect of Cinnamon (Cinnamomum cassia) as a Lipid Lowering Agent on Hypercholesterolemic Rats," Journal of Enam Medical College, vol. 3, pp. 94-98, 2013.
86. C. C. Chen et al., "Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits," (in eng), J Agric Food Chem, vol. 51, no. 18, pp. 5472-7, Aug 27 2003, doi: 10.1021/jf030065w.
87. A. L. Hopkins, M. G. Lamm, J. L. Funk, and C. Ritenbaugh, "Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies," (in eng), Fitoterapia, vol. 85, pp. 84-94, Mar 2013, doi: 10.1016/j.fitote.2013.01.003.
88. M. Mohammad-Sadeghipour, M. Mahmoodi, M. Noroozi Karimabad, M. R. Mirzaei, and M. R. Hajizadeh, "Diosgenin and 4-Hydroxyisoleucine from Fenugreek Are Regulators of Genes Involved in Lipid Metabolism in The Human Colorectal Cancer Cell Line SW480," (in eng), Cell J, vol. 22, no. 4, pp. 514-522, Jan 2021, doi: 10.22074/cellj.2021.6751.
89. A. Stark and Z. Madar, "The effect of an ethanol extract derived from fenugreek (Trigonella foenum-graecum) on bile acid absorption and cholesterol levels in rats," The British journal of nutrition, vol. 69, pp. 277-87, 02/01 1993, doi: 10.1079/BJN19930029.
90. A. Moosa, M. Rashid, A. Z. S. Asadi, N. Ara, and M. Ferdaus, "Hypolipidemic effects of fenugreek seed powder," Bangladesh Journal of Pharmacology, vol. 1, 06/01 2006, doi: 10.3329/bjp.v1i2.490.
91. M. O. Hoq, "A cardio protective medicinal plant Terminalia arjuna: evidence from the traditional medicine and recent research," magnesium, vol. 12, no. 13, pp. 14-15.
92. M. Vijayakumar, G. Jagadeesan, and E. Bharathi, "Protective role of Terminalia arjuna seed extract formulations against cardiotoxicity induced by mercuric chloride in wister rats," Int. J. Pharmac. & Biol. Arch, vol. 5, pp. 158-165, 2014.
93. D. Rodriguez-Leyva, C. M. C. Dupasquier, R. McCullough, and G. N. Pierce, "The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid," (in eng), Can J Cardiol, vol. 26, no. 9, pp. 489-496, 2010, doi: 10.1016/s0828-282x(10)70455-4.
94. K. Vijaimohan, M. Jainu, K. E. Sabitha, S. Subramaniyam, C. Anandhan, and C. S. Shyamala Devi, "Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats," (in eng), Life Sci, vol. 79, no. 5, pp. 448-54, Jun 27 2006, doi: 10.1016/j.lfs.2006.01.025.
95. S. M. Namayandeh, F. Kaseb, and S. Lesan, "Olive and sesame oil effect on lipid profile in hypercholesterolemic patients, which better?," (in eng), Int J Prev Med, vol. 4, no. 9, pp. 1059-62, Sep 2013.
96. P. R. Chen et al., "Dietary sesame reduces serum cholesterol and enhances antioxidant capacity in hypercholesterolemia," Nutrition research, vol. 25, no. 6, pp. 559-567, 2005.
97. Y. B. Park, S. M. Jeon, S. J. Byun, H. S. Kim, and M. S. Choi, "Absorption of intestinal free cholesterol is lowered by supplementation of Areca catechu L. extract in rats," (in eng), Life Sci, vol. 70, no. 16, pp. 1849-59, Mar 8 2002, doi: 10.1016/s0024-3205(02)01485-6.
98. G.-Y. Tang et al., "Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review," (in eng), International journal of molecular sciences, vol. 20, no. 24, p. 6196, 2019, doi: 10.3390/ijms20246196.
99. M. Hisashi et al., "Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles," Journal of ethnopharmacology, vol. 17, no. 3, pp. 213-224, 1986.
100. A. Trovato, M. T. Monforte, R. Barbera, A. Rossitto, E. M. Galati, and A. M. Forestieri, "Effects of fruit juices of Citrus sinensis L. and Citrus limon L. on experimental hypercholesterolemia in the rat," (in eng), Phytomedicine, vol. 2, no. 3, pp. 221-7, Jan 1996, doi: 10.1016/s0944-7113(96)80046-8.
101. A. Sharma, R. Mathur, and V. P. Dixit, "Prevention of hypercholesterolemia and atherosclerosis in rabbits after supplementation of Myristica fragrans seed extract," (in eng), Indian J Physiol Pharmacol, vol. 39, no. 4, pp. 407-10, Oct 1995.
102. N. S. Onyenibe, K. T. Fowokemi, and O. B. Emmanuel, "African Nutmeg (Monodora Myristica) Lowers Cholesterol and Modulates Lipid Peroxidation in Experimentally Induced Hypercholesterolemic Male Wistar Rats," (in eng), Int J Biomed Sci, vol. 11, no. 2, pp. 86-92, Jun 2015.
103. T. K. Behera, S. Behera, L. Bharathi, K. J. John, P. W. Simon, and J. E. Staub, "2 bitter gourd: botany, horticulture, breeding," Horticultural reviews, vol. 37, p. 101, 2010.
104. R. Noguchi, Y. Yasui, R. Suzuki, M. Hosokawa, K. Fukunaga, and K. Miyashita, "Dietary Effects of Bitter Gourd Oil on Blood and Liver Lipids of Rats," Archives of Biochemistry and Biophysics, vol. 396, no. 2, pp. 207-212, 2001/12/15/ 2001, doi: https://doi.org/10.1006/abbi.2001.2624.
105. M. Abbey, P. Clifton, M. Kestin, B. Belling, and P. Nestel, "Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans," (in eng), Arteriosclerosis, vol. 10, no. 1, pp. 85-94, Jan-Feb 1990, doi: 10.1161/01.atv.10.1.85.
106. B. Daggy, C. Arost, and A. Bensadoun, "Dietary fish oil decreases VLDL production rates," Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, vol. 920, no. 3, pp. 293-300, 1987.
107. M. Mayilvaganan, S. P. Singh, and R. P. Johari, "Hypocholesterolemic effect of protein prepared from Phaseolus aconitifolius (Jacq.)," (in eng), Indian J Exp Biol, vol. 42, no. 9, pp. 904-8, Sep 2004.
108. B. Lestari and E. Meiyanto, "A Review: The Emerging Nutraceutical Potential of Pumpkin Seeds," Indonesian Journal of Cancer Chemoprevention, vol. 9, p. 92, 07/03 2018, doi: 10.14499/indonesianjcanchemoprev9iss2pp92-101.